Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maud Maillard

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancers|December 9, 2020
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue SarcomaMaud Maillard, Christine Chevreau, Félicien Le Louedec, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.
Nature Communications|January 29, 2025
Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemiaZhenhua Li, Huanbin Zhao, Wenjian Yang, et al.
Nature Communications|October 8, 2025
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemiaLouise Ahlgren, Mattias Pilheden, Helena Sturesson, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancers|December 9, 2020
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue SarcomaMaud Maillard, Christine Chevreau, Félicien Le Louedec, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.
Nature Communications|January 29, 2025
Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemiaZhenhua Li, Huanbin Zhao, Wenjian Yang, et al.
Nature Communications|October 8, 2025
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemiaLouise Ahlgren, Mattias Pilheden, Helena Sturesson, et al.
Pageof 2